Rchr
J-GLOBAL ID：201801009681904013
Update date: Jan. 30, 2024
Koh Yoko
Koh Yoko
Affiliation and department：
Research field (1)：
Urology
Research theme for competitive and other funds (2)：
- 2020 - 2023 Establishment of precisoin medicine for malti-omics approaches using cancer tissue
- 2020 - 2022 Elucidation of PD-L1 expression mechanism and establishment as a therapeutic selection marker for renal cell carcinoma by integrated analysis of cancer genomics and proteomics
Papers (87)：
-
Kentaro Jingushi, Atsunari Kawashima, Takuro Saito, Takayuki Kanazawa, Daisuke Motooka, Tomonori Kimura, Masashi Mita, Akinaru Yamamoto, Toshihiro Uemura, Gaku Yamamichi, et al. Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients. Cancer immunology, immunotherapy : CII. 2022. 71. 12. 2999-3011
-
Gaku Yamamichi, Taigo Kato, Satoru Yumiba, Eisuke Tomiyama, Yoko Koh, Kosuke Nakano, Makoto Matsushita, Yujiro Hayashi, Yu Ishizuya, Tadashi Watabe, et al. Diagnostic and prognostic significance of tartrate-resistant acid phosphatase type 5b in newly diagnosed prostate cancer with bone metastasis: A real-world multi-institutional study. International journal of urology : official journal of the Japanese Urological Association. 2022. 30. 1. 70-76
-
Akinaru Yamamoto, Atsunari Kawashima, Toshihiro Uemura, Gaku Yamamichi, Eisuke Tomiyama, Yoko Koh, Makoto Matsushita, Taigo Kato, Koji Hatano, Motohide Uemura, et al. Anticancer maintenance chemotherapy prolonged prognosis of metastatic urothelial carcinoma patients: A single institute retrospective study using propensity score matching. International journal of urology : official journal of the Japanese Urological Association. 2022. 29. 11. 1294-1303
-
松下 慎, 藤田 和利, 林 拓自, 香山 尚子, 元岡 大祐, 長谷 拓明, 神宮司 健太郎, 山本 顕生, 植村 俊彦, 山道 岳, et al. 腸内細菌による前立腺癌増殖制御メカニズムの解明. 泌尿器外科. 2022. 35. 8. 858-859
-
Eisuke Tomiyama, Kazutoshi Fujita, Kyosuke Matsuzaki, Ryohei Narumi, Akinaru Yamamoto, Toshihiro Uemura, Gaku Yamamichi, Yoko Koh, Makoto Matsushita, Yujiro Hayashi, et al. EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer. British journal of cancer. 2022. 127. 7. 1312-1323
ｍore...
MISC (58)：
-
Taigo Kato, Kazuma Kiyotani, Akinaru Yamamoto, Toshihiro Uemura, Gaku Yamamichi, Eisuke Tomiyama, Yoko Koh, Makoto Matsushita, Koji Hatano, Atsunari Kawashima, et al. Early dynamics of T cell clonotypes as potential surrogate biomarker for immune checkpoint inhibitors. CANCER SCIENCE. 2022. 113
-
Taigo Kato, Eisuke Tomiyama, Yoko Koh, Makoto Matsushita, Yujiro Hayashi, Kosuke Nakano, Yu Ishizuya, Cong Wang, Koji Hatano, Atsunari Kawashima, et al. T cell receptor sequencing predict early response for immune-check point inhibitors in urological cancer. CANCER SCIENCE. 2021. 112. 398-398
-
松下慎, 藤田和利, 藤田和利, 林拓自, 香山尚子, 元岡大祐, 長谷拓明, 神宮司健太郎, 山道岳, 弓場覚, et al. 高脂肪食摂取前立腺癌マウスモデルを用いた腸内細菌による代謝産物を介した癌増殖メカニズムの解明. 日本アンドロロジー学会総会記事. 2021. 40th
-
Taigo Kato, Eisuke Tomiyama, Yoko Koh, Makoto Matsushita, Kosuke Nakano, Yujiro Hayashi, Cong Wang, Yu Ishizuya, Koji Hatano, Takeshi Ujike, et al. IDENTIFICATION OF EARLY PREDICTIVE BIOMARKER FOR IMMUNE CHECKPOINT INHIBITORS BY T CELL RECEPTOR REPERTOIRE ANALYSIS IN ADVANCED KIDNEY CANCER PATIENTS. JOURNAL OF UROLOGY. 2020. 203. E234-E234
-
松下慎, 藤田和利, 林拓自, 冨山栄輔, 洪陽子, 中野剛佑, 林裕次郎, 加藤大悟, 加藤大悟, 波多野浩士, et al. 高脂肪食摂取前立腺癌モデルマウスの前立腺組織の網羅的遺伝子発現解析による,高脂肪食が促進する癌増殖のメカニズムの解明. 日本アンドロロジー学会総会記事. 2020. 39th
ｍore...
Work history (6)：
Return to Previous Page
